BIODESIX, INC. (BDSX) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Win.
31/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 9 wins, 3 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinBDSX / S&P 55.52% / 15.20% |
WinBDSX / S&P 34.46% / 15.00% |
LoseBDSX / S&P -43.56% / 50.40% |
| 2026-Q12/3 |
WinBDSX / S&P 113.24% / -4.33% |
WinBDSX / S&P 29.05% / 11.30% |
LoseBDSX / S&P -1.74% / 27.70% |
| 2025-Q42/3 |
LoseBDSX / S&P -9.93% / 2.65% |
WinBDSX / S&P 24.08% / 9.00% |
WinBDSX / S&P 76.23% / 13.40% |
| 2025-Q33/3 |
WinBDSX / S&P 33.87% / 8.12% |
WinBDSX / S&P 22.29% / 4.61% |
WinBDSX / S&P 208.19% / 13.45% |
| 2025-Q22/3 |
LoseBDSX / S&P -54.88% / 10.94% |
WinBDSX / S&P 25.70% / 4.83% |
WinBDSX / S&P 1124.44% / 10.63% |
| 2025-Q12/3 |
LoseBDSX / S&P -59.15% / -4.27% |
WinBDSX / S&P 35.76% / 4.98% |
WinBDSX / S&P 646.30% / 10.57% |
| 2024-Q42/3 |
LoseBDSX / S&P -14.04% / 2.41% |
WinBDSX / S&P 45.30% / 5.25% |
WinBDSX / S&P 314.06% / 6.15% |
| 2024-Q33/3 |
WinBDSX / S&P 16.34% / 5.89% |
WinBDSX / S&P 48.92% / 5.89% |
WinBDSX / S&P 94.32% / 6.11% |
| 2024-Q22/3 |
WinBDSX / S&P 6.99% / 4.28% |
WinBDSX / S&P 46.25% / 5.38% |
LoseBDSX / S&P -58.33% / 5.12% |
| 2024-Q11/3 |
LoseBDSX / S&P -22.28% / 10.56% |
WinBDSX / S&P 34.70% / 5.71% |
LoseBDSX / S&P -58.78% / 5.59% |
| 2023-Q41/3 |
LoseBDSX / S&P 11.52% / 11.69% |
WinBDSX / S&P 28.46% / 6.81% |
LoseBDSX / S&P -59.24% / 7.78% |
| 2023-Q32/3 |
WinBDSX / S&P 34.15% / -3.27% |
WinBDSX / S&P 22.88% / 7.52% |
LoseBDSX / S&P -49.13% / -5.03% |
| 2023-Q21/3 |
LoseBDSX / S&P -33.87% / 8.74% |
WinBDSX / S&P 33.24% / 9.50% |
LoseBDSX / S&P -40.00% / -8.57% |
| 2023-Q11/3 |
LoseBDSX / S&P -19.13% / 7.50% |
WinBDSX / S&P 26.51% / 10.77% |
LoseBDSX / S&P BDSX unavailable / -15.69% |
| 2022-Q41/3 |
WinBDSX / S&P 81.10% / 7.56% |
LoseBDSX / S&P -29.89% / 11.88% |
LoseBDSX / S&P BDSX unavailable / -17.99% |
| 2022-Q30/3 |
LoseBDSX / S&P -22.56% / -4.88% |
LoseBDSX / S&P -51.79% / 13.47% |
LoseBDSX / S&P BDSX unavailable / -1.41% |
| 2022-Q21/3 |
WinBDSX / S&P -2.96% / -16.10% |
LoseBDSX / S&P -59.40% / 13.71% |
LoseBDSX / S&P BDSX unavailable / 11.04% |
| 2022-Q10/3 |
LoseBDSX / S&P -68.05% / -4.60% |
LoseBDSX / S&P -53.57% / 15.97% |
LoseBDSX / S&P BDSX unavailable / 42.23% |
| 2021-Q41/3 |
LoseBDSX / S&P -35.64% / 11.03% |
WinBDSX / S&P 19.64% / 15.00% |
LoseBDSX / S&P BDSX unavailable / 96.40% |
| 2021-Q31/3 |
LoseBDSX / S&P -37.77% / 0.58% |
WinBDSX / S&P 177.29% / 10.77% |
LoseBDSX / S&P BDSX unavailable / 69.42% |
| 2021-Q21/3 |
LoseBDSX / S&P -34.96% / 8.55% |
WinBDSX / S&P 257.22% / 6.58% |
LoseBDSX / S&P BDSX unavailable / 51.81% |
| 2021-Q10/3 |
LoseBDSX / S&P 0.74% / 6.17% |
LoseBDSX / S&P BDSX unavailable / -1.06% |
LoseBDSX / S&P BDSX unavailable / 7.39% |
| 2020-Q40/3 |
LoseBDSX / S&P BDSX unavailable / 12.15% |
LoseBDSX / S&P BDSX unavailable / -3.72% |
LoseBDSX / S&P BDSX unavailable / -33.42% |
| 2020-Q30/3 |
LoseBDSX / S&P BDSX unavailable / 8.93% |
LoseBDSX / S&P BDSX unavailable / -2.04% |
LoseBDSX / S&P BDSX unavailable / -27.10% |
| 2020-Q20/3 |
LoseBDSX / S&P BDSX unavailable / 20.54% |
LoseBDSX / S&P BDSX unavailable / -0.46% |
LoseBDSX / S&P BDSX unavailable / -27.11% |
| 2020-Q10/3 |
LoseBDSX / S&P BDSX unavailable / -19.60% |
LoseBDSX / S&P BDSX unavailable / 3.47% |
LoseBDSX / S&P BDSX unavailable / -14.75% |
| 2019-Q40/3 |
LoseBDSX / S&P BDSX unavailable / 9.07% |
LoseBDSX / S&P BDSX unavailable / 5.36% |
LoseBDSX / S&P BDSX unavailable / 2.99% |
| 2019-Q30/3 |
LoseBDSX / S&P BDSX unavailable / 1.70% |
LoseBDSX / S&P BDSX unavailable / 5.02% |
LoseBDSX / S&P BDSX unavailable / 0.21% |
| 2019-Q20/3 |
LoseBDSX / S&P BDSX unavailable / 4.30% |
LoseBDSX / S&P BDSX unavailable / 6.64% |
LoseBDSX / S&P BDSX unavailable / 8.65% |
| 2019-Q10/3 |
LoseBDSX / S&P BDSX unavailable / 13.65% |
LoseBDSX / S&P BDSX unavailable / 8.12% |
LoseBDSX / S&P BDSX unavailable / 14.29% |
| 2018-Q40/3 |
LoseBDSX / S&P BDSX unavailable / -13.52% |
LoseBDSX / S&P BDSX unavailable / 9.05% |
LoseBDSX / S&P BDSX unavailable / 18.23% |
| 2018-Q30/3 |
LoseBDSX / S&P BDSX unavailable / 7.71% |
LoseBDSX / S&P BDSX unavailable / 10.21% |
LoseBDSX / S&P BDSX unavailable / 19.06% |
| 2018-Q20/3 |
LoseBDSX / S&P BDSX unavailable / 3.43% |
LoseBDSX / S&P BDSX unavailable / 9.03% |
LoseBDSX / S&P BDSX unavailable / 14.46% |
| 2018-Q10/3 |
LoseBDSX / S&P BDSX unavailable / -0.76% |
LoseBDSX / S&P BDSX unavailable / 7.68% |
LoseBDSX / S&P BDSX unavailable / 12.46% |
| 2017-Q40/3 |
LoseBDSX / S&P BDSX unavailable / 6.64% |
LoseBDSX / S&P BDSX unavailable / 7.03% |
LoseBDSX / S&P BDSX unavailable / 13.82% |
| 2017-Q30/3 |
LoseBDSX / S&P BDSX unavailable / 4.48% |
LoseBDSX / S&P BDSX unavailable / 5.68% |
LoseBDSX / S&P BDSX unavailable / 17.57% |
| 2017-Q20/3 |
LoseBDSX / S&P BDSX unavailable / 3.09% |
LoseBDSX / S&P BDSX unavailable / 4.83% |
LoseBDSX / S&P BDSX unavailable / 17.74% |
| 2017-Q10/3 |
LoseBDSX / S&P BDSX unavailable / 6.07% |
LoseBDSX / S&P BDSX unavailable / 3.67% |
LoseBDSX / S&P BDSX unavailable / 13.32% |
| 2016-Q40/3 |
LoseBDSX / S&P BDSX unavailable / 3.82% |
LoseBDSX / S&P BDSX unavailable / 2.09% |
LoseBDSX / S&P BDSX unavailable / 7.05% |
| 2016-Q30/3 |
LoseBDSX / S&P BDSX unavailable / 3.85% |
LoseBDSX / S&P BDSX unavailable / 0.20% |
LoseBDSX / S&P BDSX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | BDSX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 233.49% | 20.78% |
| Annualized return | 233.49% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | BDSX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -85.17% | 83.14% |
| Annualized return | -31.73% | 12.86% |
10Y · 2020-10-28 to 2026-08-27
| Metric | BDSX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -88.88% | 319.30% |
| Annualized return | -19.72% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |